Asia
Tencent WeSure, Tencent’s insurance platform, announced it has partnered with the Ministry of Civil Affairs of the People’s Republic of China and Tencent Foundation to launch nationwide Public Welfare and Insurance Protection Program
Although news of the COVID-19 pandemic has tended to dominate the news cycle, including for the biopharma industry, there were a number of clinical trial announcements last week. Here’s a look.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Genedata Profiler used for biomarker discovery and validation projects in support of Chugai’s early proof of concept research initiatives
Companies from across the globe provide updates on their pipelines and business.
As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2020. We want to know how the coronavirus outbreak may be impacting your work and your workplace.
Numerous organizations are cancelling or postponing activities that involve large groups of people.
Arkin Holdings launched a new $140 million fund that aims to invest in 10 to 12 private companies developing different types of therapies for indications with high unmet needs.
GlobalData, a leading data and analytics company, pegged the 10 drugs to hit sales of $1 billion and more per year.
New microfluidic process enables researchers to create unique environment for developing medicine that cannot be achieved through conventional methods, paving the way for more potent, high-quality drugs
PRESS RELEASES